Houlihan Lokey, Inc.· HLI
🇺🇸 US · MidSP400NYSE
- Price
- $128.25
- Day
- +2.21%
- Mkt Cap
- $8.96B
- 52W Range
- $112.83 – $211.78
- Volume
- 615.0K
- Beta
- 0.96
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Argent Capital Management LLC decreased its stake in shares of Houlihan Lokey, Inc. (NYSE: HLI) by 14.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 202,422 shares of the financial services provider's stock after selling 33,673 shares during the period. Argent Capital Management
Read full article
Houlihan Lokey NYSE: HLI reported first-quarter fiscal 2027 revenue of $511 million and adjusted earnings per share of $1.35, with management characterizing the quarter as a temporary disruption rather than a fundamental change in its outlook.
Read full article
Houlihan Lokey, Inc. (HLI) Q1 2027 Earnings Call Transcript
Read full article
LOS ANGELES--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI) (“Houlihan Lokey” or the “Company”) today reported financial results for its first quarter ended June 30, 2026. For the first quarter ended June 30, 2026, revenues were $511 million, compared with $605 million for the first quarter ended June 30, 2025. Net income attributable to Houlihan Lokey, Inc. was $78 million, or $1.15 per diluted share, for the first quarter ended June 30, 2026, compared with $98 million, or $1.42 per diluted.
Read full article
The headline numbers for Houlihan Lokey (HLI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article
Houlihan Lokey (HLI) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $2.14 per share a year ago.
Read full article
Houlihan Lokey (HLI) will show the pressures of the environment on results in a few days' time. The issue is that being mid-market and therefore sponsor indexed, and also tech indexed, not a lot is going right for them when there's upside risk on cost of capital. Restructuring activity may sequentially improve, but robust US macro conditions limit major upside.
Read full article
Houlihan Lokey (HLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article